Sources of the figures for Iran
| Source | Type | Rows | Indicators | Years | Read from | Retrieved |
|---|---|---|---|---|---|---|
| UNAIDS AIDSinfo | Modelled estimate | 169 | 26 | 2000–2024 | aidsinfo.unaids.org | 2026-10-20 |
| WHO Global Tuberculosis Programme | Programme record | 100 | 11 | 2000–2024 | extranet.who.int | 2026-10-16 |
| Global Fund Data Service | Programme record | 74 | 5 | 2017–2025 | fetch.theglobalfund.org | 2026-10-12 |
| IATI, through d-portal | Expenditure account | 44 | 3 | 2005–2026 | d-portal.org | 2026-10-12 |
| OECD Creditor Reporting System | Expenditure account | 41 | 2 | 2003–2024 | sdmx.oecd.org | 2026-10-12 |
| WHO HIV testing services dashboard | Programme record | 30 | 4 | 2018–2024 | eic-database-290813.ew.r.appspot.com | 2026-10-14 |
| World Bank Open Data | Modelled estimate | 26 | 1 | 2000–2025 | api.worldbank.org | 2026-10-12 |
| WHO Global Health Observatory | Programme record | 24 | 2 | 2022–2024 | ghoapi.azureedge.net | 2026-10-12 |
| Global Fund allocations | Expenditure account | 4 | 1 | 2017–2026 | fetch.theglobalfund.org | 2026-10-12 |
Indicators held
| Indicator | Domain | Unit | Rows | Years | Sources | Most recent value |
|---|---|---|---|---|---|---|
| Country-reported HIV expenditure, all sources | Financing | USD | 1 | 2012 | UNAIDS AIDSinfo | $74.5m (2012) |
| Domestic funding received by the national TB programme | Financing | USD | 3 | 2018–2020 | WHO Global Tuberculosis Programme | $1.1m (2020) |
| Expected domestic funding for the national TB programme | Financing | USD | 3 | 2021–2023 | WHO Global Tuberculosis Programme | $7.2m (2023) |
| External HIV financing (all donors, ODA) | Financing | USD | 22 | 2003–2024 | OECD Creditor Reporting System | $3.8m (2024) |
| External HIV financing from governments other than the United States (IATI) | Financing | USD | 7 | 2013–2025 | IATI, through d-portal | $0 (2025) |
| External HIV financing from multilateral bodies other than the Global Fund (IATI) | Financing | USD | 15 | 2012–2026 | IATI, through d-portal | $30k (2026) |
| Global Fund HIV allocation for a whole three-year cycle, not an annual figure | Financing | USD per three-year allocation cycle | 4 | 2017–2026 | Global Fund allocations | 8,579,383 (2026) |
| Global Fund HIV disbursements to the country | Financing | USD | 41 | 2005–2026 | IATI, through d-portal, OECD Creditor Reporting System | $2.5m (2026) |
| Global Fund funding received by the national TB programme | Financing | USD | 1 | 2018 | WHO Global Tuberculosis Programme | $0 (2018) |
| USAID funding received by the national TB programme | Financing | USD | 1 | 2018 | WHO Global Tuberculosis Programme | $0 (2018) |
| % of ALL PLHIV who are virally suppressed | Treatment cascade | percent | 1 | 2024 | UNAIDS AIDSinfo | 45.0% (2024) |
| % of PLHIV on ART (second 95, PLHIV base) | Treatment cascade | percent | 3 | 2024 | UNAIDS AIDSinfo | 49.0% (2024) |
| % of PLHIV who have been diagnosed (first 95) | Treatment cascade | percent | 4 | 2024 | UNAIDS AIDSinfo | 62.0% (2024) |
| % of estimated HIV-positive incident TB cases on TB treatment and ART | Treatment cascade | percent | 20 | 2003–2024 | UNAIDS AIDSinfo | 66.6% (2024) |
| % of people currently enrolled in HIV treatment started on TB preventive therapy | Treatment cascade | percent | 4 | 2021–2024 | UNAIDS AIDSinfo | 2.0% (2024) |
| % of people living with HIV on ART who completed a course of TB preventive therapy | Treatment cascade | percent | 4 | 2019–2024 | UNAIDS AIDSinfo | 81.7% (2024) |
| % of people newly enrolled in HIV treatment diagnosed with TB disease | Treatment cascade | percent | 8 | 2016–2024 | UNAIDS AIDSinfo | 2.4% (2024) |
| % of people newly enrolled in HIV treatment started on TB preventive therapy | Treatment cascade | percent | 10 | 2013–2024 | UNAIDS AIDSinfo | 6.4% (2024) |
| % of returned HIV test results that were positive | Treatment cascade | percent | 27 | 2018–2024 | UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard | 0.2% (2024) |
| HIV tests performed at a health facility | Treatment cascade | count | 6 | 2018–2024 | WHO HIV testing services dashboard | 1,228,467 (2024) |
| HIV tests performed through community outreach | Treatment cascade | count | 1 | 2019 | WHO HIV testing services dashboard | 77,721 (2019) |
| HIV tests performed with the result returned to the person | Treatment cascade | count | 35 | 2018–2024 | Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard | 1,228,467 (2024) |
| HIV-exposed infants tested within two months of birth | Treatment cascade | percent | 14 | 2010–2024 | UNAIDS AIDSinfo | 42.0% (2024) |
| HIV-positive TB patients started or continued on ART | Treatment cascade | count | 10 | 2015–2024 | WHO Global Tuberculosis Programme | 93 (2024) |
| Key-population people tested for HIV (count over the period) | Treatment cascade | count | 28 | 2017–2025 | Global Fund Data Service | By population group, sex or age only, to 2025 |
| New HIV diagnoses with a CD4 count below 200 | Treatment cascade | percent | 6 | 2015–2020 | UNAIDS AIDSinfo | 41.0% (2020) |
| Number of people on ART (PEPFAR MER TX_CURR) | Treatment cascade | count | 14 | 2017–2025 | Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 20,669 (2025) |
| People newly enrolled on ART during the year | Treatment cascade | count | 8 | 2016–2024 | WHO Global Tuberculosis Programme | 1,690 (2024) |
| Pregnant women tested for HIV in antenatal care | Treatment cascade | percent | 8 | 2017–2024 | UNAIDS AIDSinfo | 83.0% (2024) |
| Pregnant women with HIV who received ARVs for PMTCT | Treatment cascade | count | 2 | 2024–2025 | Global Fund Data Service | 128 (2025) |
| TB patients recorded as HIV-positive | Treatment cascade | count | 10 | 2015–2024 | WHO Global Tuberculosis Programme | 100 (2024) |
| TB patients with an HIV test result recorded | Treatment cascade | count | 10 | 2015–2024 | WHO Global Tuberculosis Programme | 6,858 (2024) |
| AIDS-related deaths | Epidemic estimates | count | 2 | 2024 | UNAIDS AIDSinfo | 1,700 (2024) |
| Deaths from TB among people living with HIV | Epidemic estimates | count | 50 | 2000–2024 | UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 38 (2024) |
| HIV prevalence among a key population | Epidemic estimates | percent | 4 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| HIV prevalence, ages 15-49 | Epidemic estimates | percent | 1 | 2024 | UNAIDS AIDSinfo | 0.1% (2024) |
| Incident TB cases among people living with HIV | Epidemic estimates | count | 50 | 2000–2024 | UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 140 (2024) |
| New HIV infections | Epidemic estimates | count | 2 | 2024 | UNAIDS AIDSinfo | 2,100 (2024) |
| People living with HIV | Epidemic estimates | count | 2 | 2024 | UNAIDS AIDSinfo | 40,000 (2024) |
| Key-population members reached by prevention programmes | Prevention and outreach | percent | 3 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| Key-population people reached by outreach (count over the period) | Prevention and outreach | count | 28 | 2017–2025 | Global Fund Data Service | By population group, sex or age only, to 2025 |
| Male condoms distributed in a year | Prevention and outreach | count | 5 | 2019–2024 | UNAIDS AIDSinfo | 7,893,584 (2024) |
| People receiving PrEP | Prevention and outreach | count | 4 | 2021–2024 | UNAIDS AIDSinfo | 200 (2024) |
| Estimated size of a key population | Population denominators | count | 4 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| Total population | Population denominators | count | 26 | 2000–2025 | World Bank Open Data | 92,417,681 (2025) |
Every row shown on the Iran page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.
Turn your phone to read the chart upright